Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1097/MOP.0000000000000084 http://scihub22266oqcxt.onion/10.1097/MOP.0000000000000084 C4137567!4137567 !24732566     free     free     free Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\24732566 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Curr+Opin+Pediatr 2014 ; 26 (3 ): 286-91 Nephropedia Template TP {{tp|p=24732566 |t=2014. Venous thromboembolism in critically ill children |pdf=|usr=}}{{24732566 }} gab.com Text Venous thromboembolism in critically ill children JO: Curr Opin Pediatr http://www.kidney.de/pget.php?&tw=1&pmid=24732566 #FOAvip PURPOSE OF REVIEW: To review the current literature on venous thromboembolism (VTE) in critically ill children. RECENT FINDINGS: There is an increasing concern for VTE and its complications in critically ill children. Critically ill children are at increased risk of thromboembolism because of the treatment that they are receiving and their underlying condition. A complex relationship exists between thrombosis and infection. A thrombus is a nidus for infection, while infection increases the risk of thrombosis. Pediatric-specific guidelines for the prevention and treatment of thromboembolism are lacking. Current guidelines are based on the data from adults. Novel anticoagulants are now available for use in adults. Studies are ongoing to determine their safety in children. Risk assessment tools have recently been developed to determine the risk of thromboembolism in critically ill children. Certain molecules are associated with thromboembolism in adults. SUMMARY: Pediatric critical care practitioners should be cognizant of the importance of VTE in critically ill children to allow early identification and treatment. Adequately powered clinical trials are critically needed to generate evidence that will guide the treatment and prevention of thromboembolism in critically ill children. Risk assessment tools that incorporate biomarkers may improve our ability to predict the occurrence of thromboembolism in critically ill children. Twit Text FOAVip Venous thromboembolism in critically ill children ????Curr Opin Pediatr http://www.kidney.de/pget.php?&tw=1&pmid=24732566 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=24732566 #FOAvip English Wikipedia <ref>{{Cite pmid|24732566 }}</ref> Venous thromboembolism in critically ill children #MMPMID24732566 Polikoff LA ; Faustino EV Curr Opin Pediatr 2014[Jun]; 26 (3 ): 286-91 PMID24732566 show ga PURPOSE OF REVIEW: To review the current literature on venous thromboembolism (VTE) in critically ill children. RECENT FINDINGS: There is an increasing concern for VTE and its complications in critically ill children. Critically ill children are at increased risk of thromboembolism because of the treatment that they are receiving and their underlying condition. A complex relationship exists between thrombosis and infection. A thrombus is a nidus for infection, while infection increases the risk of thrombosis. Pediatric-specific guidelines for the prevention and treatment of thromboembolism are lacking. Current guidelines are based on the data from adults. Novel anticoagulants are now available for use in adults. Studies are ongoing to determine their safety in children. Risk assessment tools have recently been developed to determine the risk of thromboembolism in critically ill children. Certain molecules are associated with thromboembolism in adults. SUMMARY: Pediatric critical care practitioners should be cognizant of the importance of VTE in critically ill children to allow early identification and treatment. Adequately powered clinical trials are critically needed to generate evidence that will guide the treatment and prevention of thromboembolism in critically ill children. Risk assessment tools that incorporate biomarkers may improve our ability to predict the occurrence of thromboembolism in critically ill children. |*Critical Illness [MESH] |*Guideline Adherence [MESH] |Anticoagulants/*therapeutic use [MESH] |Child [MESH] |Child, Preschool [MESH] |Critical Care/methods/standards [MESH] |Humans [MESH] |Intensive Care Units, Pediatric [MESH] |Practice Guidelines as Topic [MESH] |Prognosis [MESH] |Risk Assessment [MESH] |Risk Factors [MESH] |Survival Rate [MESH] |Thrombolytic Therapy/*methods [MESH] |Treatment Outcome [MESH]Venous thromboembolism in critically ill children (epmc).pdf DeepDyve Pubget Overpricing